Huntington National Bank’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Sell
440
-17
-4% -$394 ﹤0.01% 1987
2026
Q1
$9.4K Buy
457
+1
+0.2% +$23 ﹤0.01% 1882
2025
Q4
$10.8K Sell
456
-156
-25% -$3.8K ﹤0.01% 1771
2025
Q3
$15.2K Sell
612
-12
-2% -$258 ﹤0.01% 1701
2025
Q2
$14.4K Buy
624
+8
+1% +$185 ﹤0.01% 1679
2025
Q1
$13.8K Sell
616
-14
-2% -$325 ﹤0.01% 1644
2024
Q4
$12.3K Buy
630
+86
+16% +$1.7K ﹤0.01% 1702
2024
Q3
$9.91K Buy
544
+2
+0.4% +$38 ﹤0.01% 1759
2024
Q2
$9.42K Buy
542
+17
+3% +$301 ﹤0.01% 1716
2024
Q1
$10.3K Buy
525
+68
+15% +$1.44K ﹤0.01% 1669
2023
Q4
$10.5K Buy
457
+133
+41% +$2.98K ﹤0.01% 1630
2023
Q3
$7.45K Sell
324
-12
-4% -$305 ﹤0.01% 1672
2023
Q2
$8.77K Buy
+336
New +$8.87K ﹤0.01% 1606

Other funds holding PRVA

Huntington National Bank's PRVA Position: Q2 2026 in Review

Huntington National Bank reduced its Privia Health (PRVA) stake by 3.7% in Q2 2026, selling an estimated $394 and leaving 440 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1987.

Huntington National Bank first reported a position in PRVA in Q2 2023 and has held it in 13 quarters since. The position peaked at $15.2K in Q3 2025. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Huntington National Bank held 440 shares of Privia Health worth $11.3K as of Q2 2026.
  • Huntington National Bank sold 17 Privia Health shares in Q2 2026, an estimated $394.
  • Privia Health made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #1987 holding.
  • Huntington National Bank first reported a position in Privia Health in Q2 2023 and has held it in 13 quarters since.
  • Huntington National Bank's Privia Health position peaked at $15.2K in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.